|
|
The Body Covers: The 44th Interscience Conference on Antimicrobial Agents and Chemotherapy
Complete Index
Complications of HIV/HAART
Drug Resistance
New Antiretrovirals
- The Investigational NNRTI GW695634 Is Well Tolerated in Healthy Volunteers (Poster A-23)
Coverage by Paul E. Sax, M.D.
- Several Studies Examine Pharmacokinetics of Boosted Tipranavir (Posters A-455, A-456, A-457)
Coverage by Edwin DeJesus, M.D.
- Study of Failed Protease Inhibitor Elucidates Process of New Drug Creation (Poster F-485)
Coverage by Paul E. Sax, M.D.
- 10-Day Results of Small D-D4FC (Reverset) Study Suggests Activity in Treatment-Experienced, NRTI-Resistant Patients (Slide H-1130)
Coverage by Paul E. Sax, M.D.
- Prevalence of CCR5 and CXCR4 Co-Receptor Tropism in a Large HIV-Infected Cohort (Slide H-1135)
Coverage by Paul E. Sax, M.D.
- Tipranavir Demonstrates Efficacy and Safety in Treatment-Experienced Patients With Significant Protease Inhibitor Mutations (Slide H-1137a)
Coverage by Mark Holodniy, M.D., F.A.C.P., C.I.C.
- 837140, a CCR5 Antagonist, Appears Safe and Effective in 10-Day Trial (Slide H-1137b)
Coverage by Mark Holodniy, M.D., F.A.C.P., C.I.C.
Pharmacokinetics
Treatment-Experienced Patients
Treatment-Naive Patients
- Favorable Results of Quadruple-NRTI Regimen: Trizivir Plus Tenofovir (Posters H-563, H-564)
Coverage by Paul E. Sax, M.D.
- Rescue Options After Failure of Tenofovir and Epzicom in the 30009 Study (Poster H-567)
Coverage by Gerald Pierone Jr., M.D.
- Comparison of Lopinavir/Ritonavir Once Daily Vs. Twice Daily (Poster H-570)
Coverage by Paul E. Sax, M.D.
- NNRTI Versus Boosted PI for Treatment of Patients With Advanced HIV Infection: Advanz Study (Poster H-574)
Coverage by Gerald Pierone Jr., M.D.
- Quadruple-NRTI Regimen Can Provide Efficacy Similar to a 2-Class, Triple-Drug Regimen in Treatment-Naive Patients (Poster H-1131)
Coverage by Margaret Hoffman-Terry, M.D., F.A.C.P.
- Tenofovir Beats AZT in Safety and Likelihood of Success (Slide H-1137c)
Coverage by Calvin J. Cohen, M.D., M.S.
Treatment Switching/Simplification
|
Advertisement
|